Literature DB >> 26328258

Correlation study of Bcl-2, B7-H1, EGFR, VEGF and colorectal cancer.

Xiao-Feng Li1, Xian-Feng Liu1, Yong-Yan Yang1, Ai-Yong Liu1, Mei-Yun Zhang1, Xue-Feng Bai1, Hui Gao1, Xiao-Guang Guo1.   

Abstract

OBJECTIVE: To analyze the expressions of Bcl-2, B7-H1, EGFR and VEGF in colorectal cancer for the further investigation of their correlations with the clinical pathological features of colorectal cancer.
METHOD: Fresh colorectal cancer tissues and the expressions of Bcl-2, B7-H1, VEGF and EGFR in paraneoplastic normal mucosal tissues of 57 cases were tested by immunohistochemisty method, and the results were analyzed by SPSS10.0.
RESULTS: 1. Compared with paraneoplastic normal tissues, the expressions of Bcl-2 and B7-H1 in colorectal cancer tissues increased significantly with significant difference (P<0.05), while the expression of EGFR and VEGF in colorectal cancer tissues showed no significant difference with those in paraneoplastic normal tissue (P>0.05); 2. The correlation with clinical pathological features: there was significant difference of expression rates of EGFR between different genders (P<0.05); the expressions of BCL-2 and B7-H1 in colorectal cancer of the high- and medium- differentiated groups were significantly higher than those of the low-differentiated group, and the difference was significant (P<0.01); compared with the colorectal cancer patients without lymph node metastasis (Dukes stage A+B), the expression of B7-H1 in patients with lymph node metastasis (Dukes stage C+D) was significantly higher (P<0.05); 3. Within the high- and medium- differentiated colorectal cancer tissues, Bcl-2 expression rate in B7-H1 negative group was higher than the positive group with significant difference (P<0.01).
CONCLUSIONS: In colorectal carcinoma, Bcl-2, B7-H1, EGFR and VEGF were all expressed, independent from age and depth of invasion. However, the expression level of Bcl-2 and B7-H1 correlated with tissue differentiation, and the latter also had correlation with tumor staging. Meanwhile, the short-term follow-up showed that high expression of Bcl-2/B7-H1 existed in death cases. Therefore, the expression detection of Bcl-2, B7-H1 might provide a clear understanding of the biological behavior of colorectal cancer, and was important for the diagnosis, treatment and prognosis judgment of colorectal cancer.

Entities:  

Keywords:  B7-H1; Bcl-2; colorectal cancer; lymph node metastasis; pathologic staging

Year:  2015        PMID: 26328258      PMCID: PMC4548339     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  18 in total

1.  Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

Authors:  Wei-Li Zhao; Marjan Ertault Daneshpouy; Nicolas Mounier; Josette Brière; Christophe Leboeuf; Louis-François Plassa; Elisabeth Turpin; Jean-Michel Cayuela; Jean-Claude Ameisen; Christian Gisselbrecht; Anne Janin
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

Review 2.  Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

Authors:  Roy M Bremnes; Carlos Camps; Rafael Sirera
Journal:  Lung Cancer       Date:  2005-12-19       Impact factor: 5.705

Review 3.  Vascular endothelial growth factor.

Authors:  N Ferrara
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

4.  Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death.

Authors:  I Ozaki; E Tani; H Ikemoto; H Kitagawa; H Fujikawa
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

5.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Authors:  M Colombel; F Symmans; S Gil; K M O'Toole; D Chopin; M Benson; C A Olsson; S Korsmeyer; R Buttyan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Prognostic significance of Bcl-xL in human hepatocellular carcinoma.

Authors:  Jota Watanabe; Fumiki Kushihata; Kazuo Honda; Atsuro Sugita; Norihiko Tateishi; Katsumi Mominoki; Seiji Matsuda; Nobuaki Kobayashi
Journal:  Surgery       Date:  2004-06       Impact factor: 3.982

Review 7.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

8.  Bcl-Xl protein expression in laryngeal squamous cell carcinoma.

Authors:  T Krecicki; M Fraczek; J Kozlak; T Zatonski; M Jelen; D Dus
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-02

9.  Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.

Authors:  Shengdian Wang; Jürgen Bajorath; Dallas B Flies; Haidong Dong; Tasuku Honjo; Lieping Chen
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

10.  Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer.

Authors:  Ana Carneiro; Anna Isinger; Anna Karlsson; Jan Johansson; Göran Jönsson; Pär-Ola Bendahl; Dan Falkenback; Britta Halvarsson; Mef Nilbert
Journal:  BMC Cancer       Date:  2008-04-11       Impact factor: 4.430

View more
  2 in total

1.  miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.

Authors:  Qingguo Li; Xin Liang; Yuwei Wang; Xianke Meng; Ye Xu; Sanjun Cai; Zhimin Wang; Jianwen Liu; Guoxiang Cai
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

2.  Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells.

Authors:  Jing Sun; Xin Zhang; Yang Sun; Zhi-Shu Tang; Dong-Yan Guo
Journal:  Mol Med Rep       Date:  2017-04-03       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.